Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy)-Reference-Cited by-同舟云学术

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy)

Published:2020-06 Issue:6 Volume:34 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Atzori L.¹^ORCID,Mugheddu C.¹,Addis G.²,Sanna S.¹,Satta R.³^ORCID,Ferreli C.¹,Atzori M.G.²,Montesu M.A.³^ORCID,Rongioletti F.¹

Affiliation:

1. Department of Medical Sciences and Public Health Dermatology Clinic University of Cagliari Cagliari Italy

2. Dermatology Unit Nuoro San Francesco Hospital Nuoro Italy

3. Department of Surgical, Microsurgical and Medical Sciences Dermatology Clinic University of Sassari Sassari Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16473

Reference6 articles.

1. Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis

2. COVID-19 in Italy: momentous decisions and many uncertainties

3. National Institute of Statistics data 2019. URLhttp://www4.istat.it(last accessed: 1 January 2019).

4. Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department

5. Infezione da Coronavirus – Raccomandazioni SIDeMaST (Società Italiana di Dermatologia e Malattie Sessualmente Trasmesse). URLhttps://www.sidemast.org/blog/coronavirus/(last accessed: 25 February 2020).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?;International Journal of Molecular Sciences;2022-10-14

2. The impact of the SARS-CoV-2 pandemic on healthcare provision in Italy to non-COVID patients: a systematic review;Mediterranean Journal of Hematology and Infectious Diseases;2022-01-01

3. Biologics for Psoriasis during the COVID-19 Pandemic;Journal of Clinical Medicine;2021-03-30

4. Safety of secukinumab treatment in COVID ‐19 affected psoriatic patients;Dermatologic Therapy;2021-01

5. Skin manifestations of COVID‐19 in children: Part 3;Clinical and Experimental Dermatology;2020-11-18